Quest Diagnostics (NYSE:DGX) Lifted to “Buy” at StockNews.com

StockNews.com upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a report published on Wednesday. A number of other research firms have also commented on DGX. Truist Financial upped their price objective on shares of Quest Diagnostics from $145.00 to $150.00 and gave the company a […]

Leave a Reply

Your email address will not be published.

Previous post Merus (NASDAQ:MRUS) Receives $80.90 Average PT from Analysts
Next post Insider Selling: Altair Engineering Inc. (NASDAQ:ALTR) Director Sells $60,592.60 in Stock